Week 3 Flashcards

1
Q

What is pharmacokinetics?

A

What the body does to the drug: absorption, distribution, metabolism, excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Things that affect pharmacokinetics:

A
Age
Pregnancy 
Hepatic/renal disease 
Drug interactions
Ethnicity 
Metabolism
GI surgery
Nutritional status
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the fraction of unchanged drug teaching systemic circulation?

A

Bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Rate at which drug leaves site of administration and passes to systemic circulation. How drug enters the body.

A

Absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Factors affecting absorption:

A
Presence/absence of food in stomach
Blood flow to area
Formulation of drug
Size of molecule 
Ionization 
Cellular environment
Lipophilicity
Mechanism of absorption: passive diffusion or active transport
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

A drug that is more basic will be absorbed where:

A

A more basic environment such as small intestines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

A drug that is more acidic will be absorbed:

A

In a more acidic environment like the stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

This enhances renal clearance of drugs during toxicity.

A

Ion (drug) trapping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

With an acidic drug overdose what would you give for ion trapping?

A

Sodium bicarbonate to make urine more alkaline and prevent reabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

For a basic drug overdose, what would you give?

A

Ammonium chloride to make more urine more acidic and prevent reabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Most drugs are absorbed through the GI tract by:

A

Passive diffusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How the drug will distribute through the body:

A

Volume of distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Volume of distribution depends on:

A

Solubility
Charge
Size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Larger Vd will concentrate where:

A

In tissues of the body- lipophilic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Smaller Vd concentrates:

A

In the plasma- hydrophilic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Properties affecting distribution:

A

Molecular size
Lipid solubility
Ph of environment
Ionization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

A high degree of plasma protein binding can result in:

A

Restricted drug distribution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Active drugs being made less active to be excreted:

A

Metabolism/biotransformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Metabolism occurs primarily here:

A

Liver

But also: intestines, skin, lungs, kidney, and brain

20
Q

An inactive drug that becomes active with metabolism:

21
Q

Phase I reactions occur through:

A

Oxidation (most common), reduction, and hydrolysis

22
Q

What system does phase I metabolism occur:

A

Most often cytochrome 450 system

23
Q

Goal of Phase I reactions:

A

Parent drug converted to a drug more easily excreted/water soluble.

24
Q

With aging the livers capacity for metabolism through the P450 system is ___

A

Reduced by 30%

This drugs metabolized through this system reach higher levels and have prolonged half lives in the elderly

25
Explain CYP450 enzyme induction:
An inducing agent can increase the metabolism of another drug, resulting in the effect of the second drug being reduced. This can lead to therapeutic failure of the second drug.
26
Explain CYP450 enzyme inhibition:
An inhibiting drug can decrease the rate of metabolism of another drug, causing the second drugs level to rise and possibly result in harmful or reverse effect.
27
Phase II reactions are these types of reactions:
Glucurondiation Acetylation Sulfation
28
Phase II causes drugs to:
Conjugate with another substance to make drug more water soluble and easier to excrete.
29
Patients deficient in acetylation capacity (slow acetylators) may have:
Prolonged or toxic responses to normal doses of certain drugs bc of decreased rates of metabolism .
30
Factors affecting metabolism:
``` Age Gender Drug tolerance Co-morbidities Drug-drug interactions Genetic differences Diet and environment factors ```
31
Primary site of excretion is:
Kidney
32
Filtration works well for:
Hydrophilic, ionized compounds
33
Process of drugs being transferred from inside to outside the body.
Excretion
34
What types of drugs use biliary excretion:
Usually larger molecular weight drugs- erythromycin
35
Some ___ soluble drugs will get passively reabsorbed into circulation .
Lipid
36
Factors affecting renal excretion:
Renal function Protein binding Renal disease
37
If creating is elevated then creative clearance is
Decreased - drug will not be as easily excreted and there is an increased potential for toxicity
38
At a steady state, rate of clearance should be:
Equal to the amount of drug taken in
39
Time it takes the peak drug level in the bloodstream to drop by half after elimination from the body.
Half-life
40
High enough to maintain effect, low enough to prevent toxicity.
Steady state
41
Refers more broadly to the genome-wide (or an individuals entire DNA sequence) effects on drug therapy
Pharmacogenomics
42
Refers to a single or a few gene variations (called polymorphisms)
Pharmacogenetics
43
Poor metabolizers:
Slowly metabolize drug causing increase of drug in system
44
Poor metabolizers should have an increase or decrease in dosage?
Decrease
45
Ultra-rapid metabolizers:
Have an increased metabolism of drug causing therapeutic failure of drug
46
Ultra-rapid metabolizers need an increase or decrease in dosage?
Increase in dose to have effect
47
What will happen with a prodrug and an ultra rapid metabolizers?
Will become more active and become potentially toxic